Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Varying Doses of PCV7 in Seniors Previously Vaccinated With PPV23
NCT00169234Phase 2Completed
- Sponsor
- Kaiser Permanente
- Start
- May 2003
- Primary completion
- Feb 2005
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised trial of pneumococcal 7-valent conjugate vaccine in pneumonia (5 arms), sponsored by Kaiser Permanente. Primary endpoint: Immunologic response to varying doses of 7-valent pneumococcal conjugate vaccine (PCV7). Started May 2003; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT00169234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169234.